Status of antituberculosis drug resistance in Saudi Arabia 1979-98
EMHJ-Eastern Mediterranean Health Journal. 2002; 8 (4-5): 664-670
en Inglés
| IMEMR
| ID: emr-158106
ABSTRACT
All published material on the prevalence of drug-resistant tuberculosis within Saudi Arabia over the period 1979-98 was reviewed. The prevalence of single-drug-resistant tuberculosis ranged from 3.4% to 41% for isoniazid, 0% to 23.4% for rifampicin, 0.7% to 22.7% for streptomycin and 0% to 6.9% for ethambutol. The prevalence of multidrug-resistant tuberculosis [defined by WHO as resist1qance to two or more first-line antituberculosis drugs] ranged from 1.5% to 44% in different regions. No strong conclusions could be drawn owing to variations in the populations studied, geographical origins, site of Mycobacterium tuberculosis isolation [pulmonary or extrapulmonary] and drug sensitivity testing. However, the need to develop a standardized national policy for surveillance of drug-resistant tuberculosis in Saudi Arabia is clear
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Proyectos de Investigación
/
Pruebas de Sensibilidad Microbiana
/
Características de la Residencia
/
Vigilancia de la Población
/
Prevalencia
/
Epidemiología Molecular
/
Farmacorresistencia Bacteriana Múltiple
/
Antituberculosos
Tipo de estudio:
Estudio de prevalencia
/
Estudio de tamizaje
Límite:
Humanos
Idioma:
Inglés
Revista:
East Mediterr Health J.
Año:
2002
Similares
MEDLINE
...
LILACS
LIS